Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Zosuquidar

😃Good
Catalog No. T6018LCas No. 167354-41-8
Alias RS33295-198, RS 33295-198, LY-335979, LY335979

Zosuquidar (RS 33295-198) is a potent P-glycoprotein inhibitor with antitumor activity, inhibits tumor growth, significantly inhibits PD-L1 expression by triggering its autophagic degradation, and is used in the study of acute myeloid leukemia.

Zosuquidar

Zosuquidar

😃Good
Catalog No. T6018LAlias RS33295-198, RS 33295-198, LY-335979, LY335979Cas No. 167354-41-8
Zosuquidar (RS 33295-198) is a potent P-glycoprotein inhibitor with antitumor activity, inhibits tumor growth, significantly inhibits PD-L1 expression by triggering its autophagic degradation, and is used in the study of acute myeloid leukemia.
Pack SizePriceAvailabilityQuantity
25 mg1.233 €1-2 weeks
50 mg1.822 €1-2 weeks
100 mg2.332 €1-2 weeks
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Zosuquidar (RS 33295-198) is a potent P-glycoprotein inhibitor with antitumor activity, inhibits tumor growth, significantly inhibits PD-L1 expression by triggering its autophagic degradation, and is used in the study of acute myeloid leukemia.
In vitro
Zosuquidar (0.3 μM, treated for 48 hours) enhances the cytotoxic effect of DNR (P-glycoprotein substrate) in P-glycoprotein-active cell lines. [2]
Zosuquidar (5-16 μM, treated for 72 hours) alone exhibited strong cytotoxicity in drug-sensitive cell lines and multidrug resistant (MDR) cell lines. [1]
In vivo
Intraperitoneal injection of 30, 10, 3, or 1 mg/kg Zosuquidar once daily for 5 days significantly prolonged subject survival. [1]
Intraperitoneal injection of 30 mg/kg Zosuquidar once daily for 5 days observed a significant potentiation when combined with adriamycin (Doxorubicin). [1]
AliasRS33295-198, RS 33295-198, LY-335979, LY335979
Chemical Properties
Molecular Weight527.6
FormulaC32H31F2N3O2
Cas No.167354-41-8
SmilesFC1(F)[C@]2([C@@]1(C=3C([C@@H](C=4C2=CC=CC4)N5CCN(C[C@H](COC=6C7=C(C=CC6)N=CC=C7)O)CC5)=CC=CC3)[H])[H]
Relative Density.1.36 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 80 mg/mL (151.63 mM), Sonication is recommended
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.8954 mL9.4769 mL18.9538 mL94.7688 mL
5 mM0.3791 mL1.8954 mL3.7908 mL18.9538 mL
10 mM0.1895 mL0.9477 mL1.8954 mL9.4769 mL
20 mM0.0948 mL0.4738 mL0.9477 mL4.7384 mL
50 mM0.0379 mL0.1895 mL0.3791 mL1.8954 mL
100 mM0.0190 mL0.0948 mL0.1895 mL0.9477 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Zosuquidar | purchase Zosuquidar | Zosuquidar cost | order Zosuquidar | Zosuquidar chemical structure | Zosuquidar in vivo | Zosuquidar in vitro | Zosuquidar formula | Zosuquidar molecular weight